Eun Soo Lee Selected Research

Integrin alpha4

2/2010	Aberrant DNA methylation of integrin alpha4: a potential novel role for metastasis of cholangiocarcinoma.
6/2009	Differential methylation pattern of ID4, SFRP1, and SHP1 between acute myeloid leukemia and chronic myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eun Soo Lee Research Topics

Disease

13	Inflammation (Inflammations) 01/2022 - 01/2007
13	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 12/2011
9	Insulin Resistance 01/2019 - 03/2013
6	Albuminuria 01/2021 - 07/2013
6	Obesity 01/2021 - 09/2013
6	Type 2 Diabetes Mellitus (MODY) 01/2021 - 12/2011
5	Neoplasms (Cancer) 01/2019 - 06/2008
4	Fibrosis (Cirrhosis) 01/2022 - 01/2017
2	Wounds and Injuries (Trauma) 01/2022 - 01/2021
2	Non-alcoholic Fatty Liver Disease 01/2020 - 11/2018
2	Kidney Diseases (Kidney Disease) 01/2019 - 07/2013
2	Glucose Intolerance 01/2018 - 01/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2015 - 09/2013
1	Hypertrophy 01/2021
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2021
1	Fabry Disease (Fabry's Disease) 01/2021
1	Skin Diseases (Skin Disease) 01/2021
1	Diabetes Mellitus 12/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Hyperpigmentation 01/2019
1	Diabetes Complications 01/2019
1	ACTH-Secreting Pituitary Adenoma 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Body Weight (Weight, Body) 01/2018
1	Weight Gain 03/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2013
1	Hyperuricemia 09/2013
1	Hypertension (High Blood Pressure) 09/2013
1	Dyslipidemias (Dyslipidemia) 09/2013
1	Hyperinsulinism (Hyperinsulinemia) 09/2013
1	Vascular Diseases (Vascular Disease) 03/2013
1	Neoplasm Metastasis (Metastasis) 02/2010
1	Cholangiocarcinoma 02/2010
1	Leukemia 06/2009
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2009
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2009

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2014
5	CurcuminIBA 01/2022 - 05/2016
5	LipidsIBA 01/2019 - 03/2015
4	AntioxidantsIBA 01/2019 - 01/2014
3	AlbuminsIBA 01/2021 - 01/2017
3	Therapeutic UsesIBA 01/2019 - 12/2011
3	CC ChemokinesIBA 01/2017 - 07/2013
2	CytokinesIBA 01/2021 - 03/2013
2	CreatinineIBA 01/2021 - 03/2018
2	Protein Isoforms (Isoforms)IBA 12/2020 - 01/2007
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 03/2018
2	Triglycerides (Triacylglycerol)IBA 11/2018 - 01/2015
2	AdiponectinIBA 01/2017 - 03/2013
2	Uric Acid (Urate)IBA 07/2015 - 09/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 07/2013
2	Integrin alpha4IBA 02/2010 - 06/2009
1	vactosertibIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	globotriaosyl lysosphingolipidIBA 01/2021
1	NADP (NADPH)IBA 01/2021
1	alpha-Galactosidase (Beano)IBA 01/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2021
1	Dronabinol (THC)FDA LinkGeneric 01/2021
1	Beclin-1IBA 01/2021
1	EnzymesIBA 01/2021
1	tetrahydrocurcuminIBA 01/2021
1	Glycerol (Glycerine)FDA LinkGeneric 01/2021
1	PalmitatesIBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Dual OxidasesIBA 12/2020
1	isuzinaxibIBA 12/2020
1	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2020
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 12/2020
1	Melanins (Melanin)IBA 01/2019
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Angiotensin IIIBA 01/2019
1	Amyloid beta-PeptidesIBA 01/2019
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2019
1	dibenzoylmethaneIBA 01/2019
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2019
1	Protein Hydrolysates FDA Link 03/2018
1	Biomarkers (Surrogate Marker)IBA 03/2018
1	N- (3- isopropyl- 3- ((4- (4- (trifluoromethyl)pyridin- 2- yl)piperazin- 1- yl)carbonyl)cyclopentyl)- 3- methoxytetrahydro- 2H- pyran- 4- amineIBA 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	mangostinIBA 01/2017
1	sarpogrelateIBA 01/2017
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2017
1	Oleanolic AcidIBA 03/2016
1	Acetylcysteine (Siran)FDA LinkGeneric 03/2016
1	AMP-Activated Protein KinasesIBA 03/2015
1	Insulin (Novolin)FDA Link 03/2015
1	Taurine FDA Link 01/2014
1	Blood Glucose (Blood Sugar)IBA 07/2013
1	nephrinIBA 07/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2013
1	Adenosine Diphosphate (ADP)IBA 03/2013
1	LeptinIBA 03/2013
1	AngiopoietinsIBA 03/2013
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 03/2013
1	ferulic acid (sodium ferulate)IBA 12/2011
1	H-cadherin (T-cadherin)IBA 06/2009

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2018